SCHEMBL22719957

SCHEMBL22719957

CCCNC(=O)c1ncc(COCc2ccc(OC)cc2)c(C)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.42
EGLN2 Q96KS0 3/20 0.42
GAA P10253 1/20 0.42
EGLN1 Q9GZT9 4/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719925 0.88 EGLN2 (0.41) SMN1; SMN2EGLN2GAAEGLN1HDAC3
SCHEMBL29829420 0.87 SMPD1 (0.45) SMN1; SMN2EGLN2EGLN1HDAC3HDAC1
SCHEMBL12444334 0.85 EGLN1 (0.41) SMN1; SMN2EGLN1HDAC6NPC1RAB9A
SCHEMBL22719952 0.84 EPHX2 (0.41) SMN1; SMN2EGLN1NPC1RAB9AALDH1A1
SCHEMBL22283896 0.83 EGLN1 (0.47) SMN1; SMN2EGLN1HDAC6NPC1RAB9A
SCHEMBL22738417 0.77 SMN1; SMN2 (0.43) SMN1; SMN2EGLN1NPC1RAB9AALDH1A1
SCHEMBL22719898 0.76 EGLN1 (0.39) EGLN2EGLN1NPC1RAB9AMEN1
SCHEMBL2219007 0.75 SMPD1 (0.44) SMN1; SMN2EGLN2EGLN1HDAC3HDAC1
SCHEMBL1503276 0.75 AR (0.40) EGLN1HDAC3HDAC1HDAC2HDAC8
SCHEMBL1503227 0.74 HDAC6 (0.40) SMN1; SMN2EGLN1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020237374-A1 PICOLINIC ACID DERIVATIVES AND USE THEREOF FOR TREATING DISEASES ASSOCIATED WITH ELEVATED CHOLESTEROL MONTREAL HEART INSTITUTE (CA) 2020-12-03 WO disclosed
WO-2020237374-A1 PICOLINIC ACID DERIVATIVES AND USE THEREOF FOR TREATING DISEASES ASSOCIATED WITH ELEVATED CHOLESTEROL MONTREAL HEART INSTITUTE (CA) 2020-12-03 WO disclosed